191 related articles for article (PubMed ID: 1718290)
21. The action of compound WA-335 on the central nervous system.
Maj J; Baran L; Sowińska H; Gancarczyk L
Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium.
Cardoso CC; Lobato KR; Binfaré RW; Ferreira PK; Rosa AO; Santos AR; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):235-42. PubMed ID: 19059299
[TBL] [Abstract][Full Text] [Related]
23. Captopril lacks the antidepressant-like activity in animal models.
Baran L; Siwanowicz J; Nowak G; Przegaliński E
Pol J Pharmacol Pharm; 1991; 43(4):265-70. PubMed ID: 1667333
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant properties of some phosphodiesterase inhibitors.
Przegaliński E; Bigajska K
Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
[TBL] [Abstract][Full Text] [Related]
25. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
26. Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action.
Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1989; 41(4):321-30. PubMed ID: 2534521
[TBL] [Abstract][Full Text] [Related]
27. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
[TBL] [Abstract][Full Text] [Related]
28. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF
J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713
[TBL] [Abstract][Full Text] [Related]
29. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
30. Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride.
Nakagawa T; Ukai K; Kubo S
Arzneimittelforschung; 1993 Jan; 43(1):11-5. PubMed ID: 8447840
[TBL] [Abstract][Full Text] [Related]
31. Psychopharmacological effects of tianeptine analogous hetero[2,1] benzothiazepine derivatives.
Sánchez-Mateo CC; Darias V; Albertos LM; Expósito-Orta MA
Arzneimittelforschung; 2003; 53(1):12-20. PubMed ID: 12608009
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and properties of 4-substituted-1-piperazinyl-propyl derivatives of 1-phenyl-7-methylpyrimido-[4,5-d]pyrimidin-4-one.
Malinka W; Zajac HE; Dereń A; Zawisza T; Wilimowski M; Kedzierska-Goździk L; Barczyńska J; Rutkowska M; Wojewódzki W; Szelag A
Pol J Pharmacol Pharm; 1991; 43(5):369-79. PubMed ID: 1688093
[TBL] [Abstract][Full Text] [Related]
33. A 2-amino-2-oxazoline derivative as an antidepressant in mice.
Bourin M; Creuzet MH; Jarry C; Colombel MC
Arzneimittelforschung; 1988 May; 38(5):666-8. PubMed ID: 3261982
[TBL] [Abstract][Full Text] [Related]
34. Minaprine, a new drug with antidepressant properties.
Bizière K; Worms P; Kan JP; Mandel P; Garattini S; Roncucci R
Drugs Exp Clin Res; 1985; 11(12):831-40. PubMed ID: 3836113
[TBL] [Abstract][Full Text] [Related]
35. The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1983; 35(1):49-57. PubMed ID: 6604264
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
[TBL] [Abstract][Full Text] [Related]
37. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
38. Psychopharmacological profile of dexamisole.
Przegaliński E; Bigajska K; Siwanowicz J
Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
[TBL] [Abstract][Full Text] [Related]
39. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
40. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]